首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1288830

全球色素沉著病治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023至2030年預測

Global Hyperpigmentation Disorder Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

到2030年，全球對色素沉著症治療的需求將從2022年的5.8百萬美元達到近11.73百萬美元的市場規模，在2023-2030年研究期間的複合成長率為9.21%。

色素沉著症治療是治療色素沉著症的程序，色素沉著過度是一個與皮膚相關的問題。色素沉著是指與周圍皮膚相比，深色皮膚上的斑塊，通常會導致斑塊或不均勻的外觀。當黑色素細胞（一種皮膚變黑色素）在皮膚深層產生黑色素時，就會發生色素沉著過度。黑色素的過量產生會導致皮膚出現黑斑。黑色素合成減少會導致皮膚色素減退。藥妝、激光療法和化學換膚都可用於治療色素沉著過度問題。

市場動態：

對尖端技術的研究和開發投資的增加可能會鼓勵色素沉著症治療的市場擴張。與色素沉著有關的社會恥辱降低也可能有助於市場成長。與色素沉著有關的疾病發病率的增加，以及對皮膚再生和治療方法認識的提高，預計將促進色素沉著症治療市場。參與治療色素沉著症的公司正在從藥妝技術的改進和由此產生的藥妝在皮膚護理中的使用的增加中獲得經濟利益，從而擴大色素沉著症治療市場。主要參與者正在促進他們對奈米技術的投資，以開發創新和新的解決方案，這將有助於擴大色素沉著症治療市場。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構，並在全球範圍內評估競爭的吸引力。此外，這些工具還對全球色素沉著病治療市場的每個細分市場進行了全面評估。色素沉著病治療行業的成長和趨勢為這項研究提供了一個全面的方法。

區域分析：

本節涵蓋了區域前景，強調了北美、歐洲、亞太、拉丁美洲、中東和非洲的色素沉著症治療市場的當前和未來需求。此外，該報告重點關注所有突出地區的個別應用部門的需求、估計和預測。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。色素沉著病治療市場的主要參與者包括Aerolase公司、Candela公司、Cynosure、Galderma SA、iSCLINICAL、ISDIN、歐萊雅（SkinCeuticals、Skinbetterscience和La Roche-Posay）、LumenisBe有限公司、Mesoestetics、Obagi Cosmeceuticals LLC、PCA Skin、Scientis、Sente、SkinMedica（AbbVie）、SoltaMedical、ZO Skin Health Inc。這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如關鍵的合併和收購，未來的能力，夥伴關係，財務概況，合作，新產品的開發，新產品的推出，以及其他發展。

如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

區域前景銷售分析
簡介銷售分析
北美洲銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美地區國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概況、歷史和預測的銷售分析
- 歐洲分部銷售分析
- 歐洲國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概況、歷史和預測的銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉美地區銷售分析
- 概況、歷史和預測的銷售分析
- 拉美地區分部銷售分析
- 拉美地區國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉美其他地區銷售分析
中東和非洲銷售分析
- 概況、歷史和預測銷售分析
- 中東和非洲地區分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第十章：色素沉著病治療公司的競爭格局

色素沉著病治療的市場競爭
夥伴關係/合作/協議
合併和收購
新產品發布
其他方面的發展

第十一章：公司簡介

前10名公司佔有率分析
市場集中度
Aerolase Corporation
- 公司概況
- 公司收入
- 產品
- 近期發展
Candela Corporation
- 公司概況
- 公司收入
- 產品
- 近期發展
Cynosure
- 公司概覽
- 公司收入
- 產品
- 近期發展
Galderma SA
- 公司概覽
- 公司收入
- 產品
- 近期發展
iSCLINICAL
- 公司概覽
- 公司收入
- 產品
- 近期發展
ISDIN
- 公司概覽
- 公司收入
- 產品
- 近期發展
L'Oreal (SkinCeuticals Skinbetterscience & La Roche-Posay)
- 公司概覽
- 公司收入
- 產品
- 近期發展
LumenisBe Ltd.
- 公司概覽
- 公司收入
- 產品
- 近期發展
Mesoestetics
- 公司概覽
- 公司收入
- 產品
- 近期發展
Obagi Cosmeceuticals LLC
- 公司概覽
- 公司收入
- 產品
- 近期發展
PCA Skin
- 公司概覽
- 公司收入
- 產品
- 近期發展
Scientis
- 公司概覽
- 公司收入
- 產品
- 近期發展
Sente
- 公司概覽
- 公司收入
- 產品
- 近期發展
SkinMedica (AbbVie)
- 公司概覽
- 公司收入
- 產品
- 近期發展
SoltaMedical
- 公司概覽
- 公司收入
- 產品
- 近期發展
ZO Skin Health Inc.
- 公司概覽
- 公司收入
- 產品
- 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

簡介目錄圖表

Product Code: VMR11219996

The global demand for Hyperpigmentation Disorder Treatment Market is presumed to reach the market size of nearly USD 11.73 MN by 2030 from USD 5.8 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Hyperpigmentation disorder treatments are procedures to treat hyperpigmentation which is a skin-related concern. Pigmentation refers to patches on the darkened skin compared to the surrounding skin, typically resulting in a patchy or uneven look. Hyperpigmentation occurs when melanocytes, a skin-darkening pigment, generate melanin in the deep skin layers. An overproduction of melanin can cause dark patches of skin. A reduction in melanin synthesis results in skin hypopigmentation. Cosmeceuticals, laser therapy, and chemical peels can all be used to treat hyperpigmentation issues.

Market Dynamics:

Increasing investments in research and development for cutting-edge technology may encourage market expansion for hyperpigmentation disorder treatments. The diminishing of social stigma associated with pigmentation may also aid market growth. The increased prevalence of hyperpigmentation-related disorders and increased awareness of skin rejuvenation and treatment alternatives are projected to boost the hyperpigmentation disorder treatment market. Companies involved in treating hyperpigmentation disorders are benefiting financially from cosmeceutical technological improvements and the resulting rise in cosmeceutical usage in skincare hence, expanding the hyperpigmentation disorder treatment market. Key players are boosting their investments in nanotechnology to develop innovative and new solutions that will help to broaden the hyperpigmentation disorder treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hyperpigmentation disorder treatment. The growth and trends of hyperpigmentation disorder treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the hyperpigmentation disorder treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Cosmeceuticals
Laser Therapy
Chemical Peels
Microdermabrasion
Phototherapy
Others

By Disease Indication

Melasma
Post-Inflammatory Hyperpigmentation
Solar Lentigines
Others

By End-User

Hospitals
Esthetic Clinics & Dermatology Centers
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Hyperpigmentation Disorder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hyperpigmentation disorder treatment market include Aerolase Corporation, Candela Corporation, Cynosure, Galderma S.A., iSCLINICAL, ISDIN, L'Oreal (SkinCeuticals, Skinbetterscience & La Roche-Posay), LumenisBe Ltd., Mesoestetics, Obagi Cosmeceuticals LLC, PCA Skin, Scientis, Sente, SkinMedica (AbbVie), SoltaMedical, ZO Skin Health Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HYPERPIGMENTATION DISORDER TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

6.1 Overview by Treatment Type
6.2 Historical and Forecast Data
6.3 Analysis by Treatment Type
6.4 Cosmeceuticals Historic and Forecast Sales by Regions
6.5 Laser Therapy Historic and Forecast Sales by Regions
6.6 Chemical Peels Historic and Forecast Sales by Regions
6.7 Microdermabrasion Historic and Forecast Sales by Regions
6.8 Phototherapy Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY DISEASE INDICATION

7.1 Overview by Disease Indication
7.2 Historical and Forecast Data
7.3 Analysis by Disease Indication
7.4 Melasma Historic and Forecast Sales by Regions
7.5 Post-inflammatory Hyperpigmentation Historic and Forecast Sales by Regions
7.6 Solar Lentigines Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Esthetic Clinics & Dermatology Centers Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HYPERPIGMENTATION DISORDER TREATMENT COMPANIES

10.1. Hyperpigmentation Disorder Treatment Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HYPERPIGMENTATION DISORDER TREATMENT INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Aerolase Corporation
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Candela Corporation
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Cynosure
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Galderma S.A.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. iSCLINICAL
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. ISDIN
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. L'Oreal (SkinCeuticals Skinbetterscience & La Roche-Posay)
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. LumenisBe Ltd.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Mesoestetics
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Obagi Cosmeceuticals LLC
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. PCA Skin
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Scientis
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Sente
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. SkinMedica (AbbVie)
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments
11.17. SoltaMedical
- 11.17.1. Company Overview
- 11.17.2. Company Revenue
- 11.17.3. Products
- 11.17.4. Recent Developments
11.18. ZO Skin Health Inc.
- 11.18.1. Company Overview
- 11.18.2. Company Revenue
- 11.18.3. Products
- 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表